Search results
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 12 hours agoAstraZeneca is a growth...and immunology) and aims to have 20 new medicines developed by then. Today, the company has more than 180 projects ongoing in...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 5 days agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19...
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 4 days agoPrior to today's trading, shares of the drugmaker had lost 5.43% over the past month. This...that...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 1 day agoLilly currently has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank...
7,403 Shares in Pfizer Inc. (NYSE:PFE) Bought by Gerber LLC
ETF DAILY NEWS· 6 days agoGerber LLC bought a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 7,403 shares of the biopharmaceutical ...
Best Blue Chip Stocks To Buy in June 2024
GoBankingRates via AOL· 5 days agoBlue chip stocks are among the safest and most secure buys that investors can add to their portfolios. Here are some of the best blue chip stocks to...
FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label
Zacks via Yahoo Finance· 1 day agoFollowing the label expansion, Sarepta's (SRPT) Elevidys is approved to treat all DMD patients aged four years and older, regardless of ambulation...
Sarepta Stock Surges on Expanded Elevidys Approval. It’s a ‘Best-Case’ Scenario for Shares.
Barrons.com· 1 day agoThe biopharmaceutical company says the drug was approved for ambulatory and non-ambulatory people,...
Arvinas announces new R&D leadership appointments By Investing.com
Investing.com· 5 days agoToday, Arvinas, Inc. (NASDAQ:ARVN), a pharmaceutical company specializing in the development of new...